Home  >  Products  >  BTN2A3P (BTN2A3P butyrophilin, subfamily 2, member A3, pseudogene ) Blocking Peptide (the N terminal of BTN2A3P)(100ug)
BTN2A3P (BTN2A3P butyrophilin, subfamily 2, member A3, pseudogene ) Blocking Peptide (the N terminal of BTN2A3P)(100ug)

BTN2A3P (BTN2A3P butyrophilin, subfamily 2, member A3, pseudogene ) Blocking Peptide (the N terminal of BTN2A3P)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-BTN2A3P Antibody (ARP68011_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP68011
Size: 100ug
Weight: 66kDa
Gene: 54718
Format: Lyophilized powder
Target: The butyrophilin (BTN) genes are a group of major histocompatibility complex (MHC)-associated genes that encode type I membrane proteins with 2 extracellular immunoglobulin (Ig) domains and an intracellular B30.2 (PRYSPRY) domain. Three subfamilies of human BTN genes are located in the MHC class I region: the single-copy BTN1A1 gene (MIM 601610) and the BTN2 (e.g., BTN2A3) and BTN3 (e.g., BNT3A1; MIM 613593) genes, which have undergone tandem duplication, resulting in 3 copies of each (summary by Smith et al., 2010
Alternative names: BTN2A3
See Full Product Listings >